FATE Financials

Fate Therapeutics Inc - Financial statements & key metrics

Stock Price

$2.42

Market Cap

$331.03M

P/E Ratio

-1.5

EPS

$-1.33

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$13.63M

Gross Profit

Operating Income

Net Income

$-186.26M

EPS (Diluted)

$-1.64

Balance Sheet Highlights

Total Assets

$440.69M

Total Liabilities

Shareholders Equity

Cash & Equivalents

$36.06M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-122.87M

CapEx

Free Cash Flow

Profitability Metrics

Operating Margin

-1995.1%

ROE

-52.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is FATE revenue?

FATE's most recent quarterly revenue was $13.63M. Annual revenue can be calculated by summing the four most recent quarters.

Is FATE profitable?

FATE reported a loss of $186.26M in the most recent quarter.

What is FATE market cap?

FATE has a market capitalization of $331.03M, making it a small-cap stock.

Does FATE have debt?

View FATE's balance sheet for debt information.

What is FATE cash flow?

Cash flow data is available in the full financial statements.